BV vs CVAT
BrightView Holdings, Inc. and Cavitation Technologies, Inc., side by side — 8 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BV | CVAT |
|---|---|---|
| Revenue | $2.7B | $203,000 |
| Net income | $56.0M | $-113,000 |
| Gross margin | 23.3% | 81.3% |
| Net margin | 2.1% | −55.7% |
| Return on equity | 4.4% | −3487.2% |
| Diluted EPS | $0.13 | $0.00 |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | $37.6M | $-378,000 |
| Equity | $1.3B | $69,000 |
| Net debt / equity | 0.55× | −1.78× |
| Current ratio | 1.30× | 2.80× |
| Revenue CAGR 5y | 2.6% | −34.3% |
| Profit CAGR 5y | — | — |
BV bills 13166.5× the revenue of CVAT, and CVAT closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
8 years side by side
| Fiscal year | BV | CVAT |
|---|---|---|
| FY2024 | $2.8B | $203,000 |
| FY2023 | $2.8B | $1.4M |
| FY2022 | $2.8B | $433,000 |
| FY2021 | $2.6B | $1.6M |
| FY2020 | $2.3B | $537,000 |
| FY2019 | $2.4B | $1.7M |
| FY2018 | $2.4B | $1.1M |
| FY2016 | $2.2B | $1.9M |
Net income by year
Bottom line
| Fiscal year | BV | CVAT |
|---|---|---|
| FY2024 | $66.4M | $-113,000 |
| FY2023 | $-7.7M | $439,000 |
| FY2022 | $14.0M | $-2.0M |
| FY2021 | $46.3M | $-619,000 |
| FY2020 | $-41.6M | $-649,000 |
| FY2019 | $44.4M | $128,000 |
| FY2018 | $-15.1M | $-723,000 |
| FY2016 | $-52.4M | $-233,000 |
Advertisement
AdSense · Rectangle 336×280